HeartSciences Inc. (HSCS) Total liabilities 2022–2026
HeartSciences Inc. (HSCS) total liabilities at each fiscal year-end, per SEC filings.
$5.0MFY2026 · since FY2022: $8.1M → $5.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $5.0M | +25.4% |
| FY2025 | $4.0M | +83.8% |
| FY2024 | $2.2M | -28.5% |
| FY2023 | $3.1M | -62.5% |
| FY2022 | $8.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More HSCS financial trends
HSCS RevenueHSCS Net incomeHSCS Net marginHSCS Gross profitHSCS Gross marginHSCS Operating incomeHSCS Operating marginHSCS Operating cash flowHSCS Free cash flowHSCS Capital expendituresHSCS Return on equityHSCS Stock buybacksHSCS Dividends paidHSCS Total assetsHSCS Shareholders’ equityHSCS overview →